Previous 10 | Next 10 |
Cardiovascular Systems, Inc. (CSII) Q3 2020 Earnings Conference Call May 5, 2020 4:30 PM ET Company Participants Jack Nielsen – Vice President-Investor Relations and Corporate Communication Scott Ward – Chairman, President and Chief Executive Officer Jeff Points ...
Cardiovascular Systems (NASDAQ: CSII ): Q3 GAAP EPS of -$0.08 beats by $0.02 . Revenue of $61.2M (-3.3% Y/Y) misses by $3.69M . Press Release More news on: Cardiovascular Systems, Inc., Earnings news and commentary, Healthcare stocks news,
Conference Call Scheduled for Today, May 5, 2020, at 3:30 PM CT (4:30 PM ET) Healthcare system response to COVID-19 pandemic delayed atherectomy procedures and negatively impacted third quarter results Revenues of $61.2 million decreased 3.4% from third quarter last...
Live Webcast at 3:30 p.m. CT (4:30 p.m. ET) Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 third-quarter conference call on Tuesday, May 5, 2020, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this Read more ...
WEST CONCORD, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. — a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas system called the iLet ® today announced that Martha G. Aronson and Sean D. C...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meeting...
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2020 Q2 earnings Read more ...
Cardiovascular Systems, Inc. (CSII) Q2 2020 Earnings Conference Call February 5, 2020 04:30 p.m. ET Company Representatives Scott Ward - Chairman, President, Chief Executive Officer Rhonda Robb - Chief Operating Officer Jeff Points - Chief Financial Officer Dr. Ryan Egeland - C...
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...